Cormedix Inc (CRMD)
5.23
-0.19
(-3.51%)
USD |
NASDAQ |
Apr 19, 15:35
Cormedix Gross Profit (TTM): 0.00 for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.0293M |
June 30, 2023 | 0.0346M |
March 31, 2023 | 0.0556M |
December 31, 2022 | 0.0617M |
September 30, 2022 | 0.0408M |
June 30, 2022 | 0.0483M |
March 31, 2022 | 0.0212M |
December 31, 2021 | 0.042M |
September 30, 2021 | 0.0321M |
June 30, 2021 | 0.0323M |
March 31, 2021 | 0.0358M |
December 31, 2020 | 0.0344M |
September 30, 2020 | 0.0146M |
June 30, 2020 | -0.018M |
March 31, 2020 | -0.0012M |
December 31, 2019 | -0.09M |
September 30, 2019 | -0.0642M |
June 30, 2019 | 0.0154M |
March 31, 2019 | -0.0249M |
December 31, 2018 | 0.033M |
September 30, 2018 | 0.1844M |
June 30, 2018 | 0.1188M |
March 31, 2018 | 0.263M |
December 31, 2017 | 0.2144M |
Date | Value |
---|---|
September 30, 2017 | 0.0949M |
June 30, 2017 | 0.101M |
March 31, 2017 | -0.1878M |
December 31, 2016 | -0.1426M |
September 30, 2016 | -0.3202M |
June 30, 2016 | -0.3202M |
March 31, 2016 | -0.1313M |
December 31, 2015 | -0.1086M |
September 30, 2015 | -0.156M |
June 30, 2015 | -0.1408M |
March 31, 2015 | -0.1738M |
December 31, 2014 | -0.2565M |
September 30, 2014 | -0.2674M |
June 30, 2014 | -0.2832M |
March 31, 2014 | -0.2684M |
December 31, 2013 | -0.1996M |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
-0.09M
Minimum
Dec 2019
0.0617M
Maximum
Dec 2022
0.0171M
Average
0.0321M
Median
Sep 2021
Gross Profit (TTM) Benchmarks
BioXcel Therapeutics Inc | 0.119M |
Assertio Holdings Inc | 125.05M |
Verastem Inc | -- |
Ocular Therapeutix Inc | 53.16M |
PAVmed Inc | -3.969M |